S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
NASDAQ:PCVX

Vaxcyte News Headlines

$17.63
-0.51 (-2.81%)
(As of 01/19/2022 12:00 AM ET)
Add
Compare
Today's Range
$17.44
$18.75
50-Day Range
$17.63
$26.45
52-Week Range
$15.51
$29.29
Volume
407,763 shs
Average Volume
459,339 shs
Market Capitalization
$930.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.56
Get Vaxcyte News Delivered to You Automatically

Sign up to receive the latest news and ratings for PCVX and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Vaxcyte Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PCVX
News Sentiment

0.79

0.33

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PCVX Articles
This Week

6

1

PCVX Articles
Average Week



Vaxcyte (NASDAQ:PCVX) News Headlines Today

SourceHeadline
MarketBeat logoVaxcyte (NASDAQ:PCVX) Shares Down 4.5%
americanbankingnews.com - January 14 at 1:52 PM
MarketBeat logoVaxcyte (NASDAQ:PCVX) Shares Gap Down to $22.00
americanbankingnews.com - January 13 at 11:34 AM
nasdaq.com logoVaxcyte Drops 8% Following Pricing Of Offering
nasdaq.com - January 13 at 11:20 AM
finance.yahoo.com logoVaxcyte Raises $100M Via Equity To Fund Development Of Lead Pneumococcal Vaccine Candidate
finance.yahoo.com - January 13 at 11:20 AM
seekingalpha.com logoVaxcyte raises $100M capital in stock offering
seekingalpha.com - January 13 at 6:18 AM
finance.yahoo.com logoVaxcyte Announces Pricing of $100 Million Public Offering
finance.yahoo.com - January 13 at 1:17 AM
seekingalpha.com logoVaxcyte launches stock offering
seekingalpha.com - January 12 at 7:57 PM
finance.yahoo.com logoVaxcyte Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
finance.yahoo.com - January 12 at 7:57 PM
benzinga.com logoVaxcyte Announces FDA Clearance Of Investigational New Drug Application For VAX-24 For Prevention Of Invasive Pneumococcal Disease
benzinga.com - January 6 at 12:56 PM
finance.yahoo.com logoVaxcyte Announces FDA Clearance of Investigational New Drug Application for VAX-24 for the Prevention of Invasive Pneumococcal Disease
finance.yahoo.com - January 6 at 12:56 PM
finance.yahoo.com logoWall Street Analysts Think Vaxcyte, Inc. (PCVX) Could Surge 96%: Read This Before Placing a Bet
finance.yahoo.com - December 31 at 12:16 PM
insidertrades.com logoVaxcyte, Inc. (NASDAQ:PCVX) SVP Sells $150,000.00 in Stock
insidertrades.com - December 30 at 6:14 PM
insidertrades.com logoVaxcyte, Inc. (NASDAQ:PCVX) CFO Andrew Guggenhime Sells 3,100 Shares
insidertrades.com - December 28 at 6:56 PM
MarketBeat logoVaxcyte, Inc. (NASDAQ:PCVX) VP Sells $112,100.00 in Stock
americanbankingnews.com - December 28 at 6:24 PM
nasdaq.com logoVaxcyte is Now Oversold (PCVX)
nasdaq.com - December 3 at 7:51 PM
finance.yahoo.com logoDoes Vaxcyte (PCVX) Have the Potential to Rally 89% as Wall Street Analysts Expect?
finance.yahoo.com - November 15 at 12:15 PM
finance.yahoo.com logoVaxcyte to Present at Upcoming Investor Conferences
finance.yahoo.com - November 11 at 6:09 PM
finance.yahoo.com logoVaxcyte Reports Third Quarter 2021 Financial Results and Provides Business Update
finance.yahoo.com - November 10 at 8:06 PM
finance.yahoo.com logoVaxcyte Appoints Carlos Paya and Michael Kamarck to Its Board of Directors
finance.yahoo.com - October 28 at 12:28 PM
nasdaq.com logoWe're Not Very Worried About Vaxcyte's (NASDAQ:PCVX) Cash Burn Rate
nasdaq.com - October 27 at 4:07 PM
finance.yahoo.com logoHedge Fund Sentiment Is Stagnant On Vaxcyte, Inc. (PCVX)
finance.yahoo.com - October 4 at 11:57 AM
finance.yahoo.com logoNotable Vaxcyte Insider Trades $130K In Company Stock
finance.yahoo.com - September 30 at 7:18 PM
finance.yahoo.com logoVaxcyte to Present at Guggenheim 2nd Annual Vaccine and Infectious Disease Conference
finance.yahoo.com - September 29 at 2:36 AM
finance.yahoo.com logoVaxcyte to Present at 2021 Cantor Virtual Global Healthcare Conference
finance.yahoo.com - September 21 at 8:26 PM
finance.yahoo.com logoVaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans
finance.yahoo.com - September 13 at 4:54 PM
barrons.com logoVaxcyte Inc.
barrons.com - August 19 at 9:53 PM
finance.yahoo.com logoVaxcyte Reports Second Quarter 2021 Financial Results and Provides Business Update
finance.yahoo.com - August 12 at 11:22 AM
finance.yahoo.com logoVaxcyte Announces Expanded CARB-X Award to Advance Development of VAX-A1, a Vaccine to Prevent Group A Streptococcus Infections
finance.yahoo.com - August 5 at 12:14 PM
finance.yahoo.com logoKearny Financial Corp. (KRNY): Hedge Funds In Wait-and-See Mode
finance.yahoo.com - July 30 at 1:03 PM
nasdaq.com logoVaxcyte, Inc. Common Stock (PCVX)
nasdaq.com - July 4 at 9:18 AM
finance.yahoo.com logoVaxcyte Reports First Quarter 2021 Financial Results and Provides Business Update
finance.yahoo.com - May 11 at 5:55 PM
finance.yahoo.com logoVaxcyte Announces Publication of Preclinical Data Supporting the Potential of VAX-24 for the Prevention of Invasive Pneumococcal Disease
finance.yahoo.com - May 10 at 9:14 AM
finance.yahoo.com logoVaxcyte to Present at BofA Securities 2021 Health Care Conference
finance.yahoo.com - May 6 at 7:12 PM
reuters.com logoVaxcyte Inc
reuters.com - March 31 at 6:00 AM
finance.yahoo.com logoVaxcyte asks chairman Slaoui to step down after GSK harassment claim
finance.yahoo.com - March 25 at 7:35 AM
finance.yahoo.com logoUPDATE 1-Vaxcyte asks chairman Slaoui to step down after GSK harassment claim
finance.yahoo.com - March 25 at 7:35 AM
bizjournals.com logoSexual harassment claim leads to firing of former Operation Warp Speed chief. Will it impact his other board posts?
bizjournals.com - March 24 at 7:26 PM
feeds.benzinga.com logoVaxcyte to Report Fourth Quarter and Full Year 2020 Financial Results on March 29, 2021
feeds.benzinga.com - March 22 at 4:28 PM
finance.yahoo.com logoWe Think Vaxcyte (NASDAQ:PCVX) Can Easily Afford To Drive Business Growth
finance.yahoo.com - March 15 at 2:49 PM
bizjournals.com logoPeninsula vaccine maker lands lease at big Alexandria project
bizjournals.com - January 26 at 6:36 PM
finance.yahoo.com logoVaxcyte Announces Publication of Preclinical Proof-of-Concept Data Supporting Potential of VAX-A1, a Novel Conjugate Vaccine Designed to Prevent Group A Strep Infections
finance.yahoo.com - January 6 at 2:31 PM
finance.yahoo.com logoVaxcyte Promotes Andrew Guggenhime to President and Chief Financial Officer
finance.yahoo.com - December 22 at 1:16 PM
finance.yahoo.com logoIs PCVX A Good Stock To Buy Now?
finance.yahoo.com - December 10 at 8:42 PM
seekingalpha.com logoU.S. IPO Week Ahead: DoorDash And Airbnb Kick Off The Unicorn Parade In A 6 IPO Week
seekingalpha.com - December 6 at 4:14 PM
thestreet.com logoIPO Calendar: December 7 - 11, 2020
thestreet.com - December 5 at 11:23 PM
finance.yahoo.com logoVaxcyte to Present at Evercore ISI 3rd Annual HealthCONx Conference
finance.yahoo.com - November 24 at 7:07 PM
finance.yahoo.com logoVaxcyte to Present at Jefferies Virtual London Healthcare Conference
finance.yahoo.com - November 10 at 5:31 PM
finance.yahoo.com logoWe're Interested To See How Vaxcyte (NASDAQ:PCVX) Uses Its Cash Hoard To Grow
finance.yahoo.com - September 14 at 2:46 PM
finance.yahoo.com logoVaxcyte to Present at 2020 Cantor Virtual Global Healthcare Conference
finance.yahoo.com - September 10 at 10:03 AM
finance.yahoo.com logoVaxcyte Reports Second Quarter 2020 Financial Results and Provides Business Update
finance.yahoo.com - August 12 at 5:13 PM
Get Vaxcyte News Delivered to You Automatically

Sign up to receive the latest news and ratings for PCVX and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 1/20/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.